182 related articles for article (PubMed ID: 35111279)
1. Identification of 20(
Liang Y; Zhao J; Zou H; Zhang J; Zhang T
Oxid Med Cell Longev; 2022; 2022():6119737. PubMed ID: 35111279
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory activities of 20(R, S)-protopanaxatriol against epidermal growth factor receptor tyrosine kinase.
Zhao J; Zhang T; Liang Y; Zou H; Zhang J
Food Chem Toxicol; 2021 Sep; 155():112411. PubMed ID: 34271119
[TBL] [Abstract][Full Text] [Related]
3. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
Zhang C; Yu H; Hou J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
[TBL] [Abstract][Full Text] [Related]
4. 20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway.
Chen Y; Liu ZH; Xia J; Li XP; Li KQ; Xiong W; Li J; Chen DL
Oncol Rep; 2016 Jul; 36(1):137-46. PubMed ID: 27121661
[TBL] [Abstract][Full Text] [Related]
5. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y
Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384
[TBL] [Abstract][Full Text] [Related]
6. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
[TBL] [Abstract][Full Text] [Related]
7. Anticancer property of ginsenoside Rh2 from ginseng.
Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells.
Li C; Gao H; Feng X; Bi C; Zhang J; Yin J
J Biochem Mol Toxicol; 2020 Dec; 34(12):e22597. PubMed ID: 32762018
[TBL] [Abstract][Full Text] [Related]
9. JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
Liu X; Sun Y; Yue L; Li S; Qi X; Zhao H; Yang Y; Zhang C; Yu H
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706758
[TBL] [Abstract][Full Text] [Related]
10. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
Li Q; Li B; Dong C; Wang Y; Li Q
Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases.
Choi S; Kim TW; Singh SV
Pharm Res; 2009 Oct; 26(10):2280-8. PubMed ID: 19629651
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided identification of EGFR tyrosine kinase inhibitors using ginsenosides from Panax ginseng.
Sathishkumar N; Karpagam V; Sathiyamoorthy S; Woo MJ; Kim YJ; Yang DC
Comput Biol Med; 2013 Jul; 43(6):786-97. PubMed ID: 23668355
[TBL] [Abstract][Full Text] [Related]
13. 20(
Liang Y; Zhang T; Jing S; Zuo P; Li T; Wang Y; Xing S; Zhang J; Wei Z
Am J Chin Med; 2021; 49(3):753-765. PubMed ID: 33641655
[TBL] [Abstract][Full Text] [Related]
14. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
Liu J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
Fitoterapia; 2010 Oct; 81(7):902-5. PubMed ID: 20554003
[TBL] [Abstract][Full Text] [Related]
15. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons.
Lee E; Kim S; Chung KC; Choo MK; Kim DH; Nam G; Rhim H
Eur J Pharmacol; 2006 Apr; 536(1-2):69-77. PubMed ID: 16563373
[TBL] [Abstract][Full Text] [Related]
16. Computational and Synthetic approach with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC).
Karnik KS; Sarkate AP; Tiwari SV; Azad R; Burra PVLS; Wakte PS
Bioorg Chem; 2021 Feb; 107():104612. PubMed ID: 33476869
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
[TBL] [Abstract][Full Text] [Related]
18. [Effects of ginsenoside Rh2(GS-Rh2) on cell cycle of Eca-109 esophageal carcinoma cell line].
Li L; Qi FY; Liu JR; Zuo LF
Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(20):1617-21. PubMed ID: 16422547
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
20. Identification of BACE1 inhibitors from Panax ginseng saponins-An Insilco approach.
Karpagam V; Sathishkumar N; Sathiyamoorthy S; Rasappan P; Shila S; Kim YJ; Yang DC
Comput Biol Med; 2013 Sep; 43(8):1037-44. PubMed ID: 23816176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
